| 1.69 -0.16 (-8.65%) | 12-12 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.27 | 1-year : | 2.66 |
| Resists | First : | 1.95 | Second : | 2.27 |
| Pivot price | 1.61  |
|||
| Supports | First : | 1.43 | Second : | 1.1 |
| MAs | MA(5) : | 1.72 |
MA(20) : | 1.53 |
| MA(100) : | 1.29 |
MA(250) : | 1.59 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 78.5 |
D(3) : | 76.9 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 2.79 | Low : | 0.96 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ APYX ] has closed below upper band by 38.3%. Bollinger Bands are 70.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.86 - 1.87 | 1.87 - 1.88 |
| Low: | 1.58 - 1.59 | 1.59 - 1.6 |
| Close: | 1.67 - 1.69 | 1.69 - 1.7 |
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Tue, 10 Dec 2024
Why Is Apyx Medical Corporation (APYX) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now? - Insider Monkey
Thu, 05 Dec 2024
Apyx Medical looks to raise $7M through direct offering - MSN
Wed, 27 Nov 2024
Apyx Medical to Present at Piper Sandler Healthcare Conference, Showcase Helium Plasma Tech | APYX Stock News - StockTitan
Wed, 27 Nov 2024
Apyx Medical Corporation to Participate in the Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire
Sat, 23 Nov 2024
Apyx Medical Corporation (NASDAQ:APYX) Surges 30% Yet Its Low P/S Is No Reason For Excitement - Simply Wall St
Fri, 08 Nov 2024
Apyx Medical Raises $7M Through Direct Stock Offering to Nantahala Capital - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 38 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 16.1 (%) |
| Held by Institutions | 40.4 (%) |
| Shares Short | 235 (K) |
| Shares Short P.Month | 244 (K) |
| EPS | -0.82 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.76 |
| Profit Margin | -57.9 % |
| Operating Margin | -45.7 % |
| Return on Assets (ttm) | -21.9 % |
| Return on Equity (ttm) | -110.3 % |
| Qtrly Rev. Growth | -10.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.3 |
| EBITDA (p.s.) | -0.58 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | 4 (M) |
| PE Ratio | -2.07 |
| PEG Ratio | 0 |
| Price to Book value | 2.19 |
| Price to Sales | 1.29 |
| Price to Cash Flow | -6.93 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|